Chemical Structure (Omnipaque 01)
Omnipaque Injection, Solution
Product Images NDC 0407-1413
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Omnipaque (NDC 0407-1413). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ge Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (300 mg Iodine/mL Bottle Box Label)
This text provides information about a product from GE Healthcare, specifically a vial of iohexol injection in a pharmacy bulk package. The product comes in 10 bottles of 500mL each with an NDC code 0407-1413-72. It is not suitable for direct infusion and should be used for various purposes such as intrathecal, intravenous, rectal, intra-arterial, or body cavity use. The dosage and administration information is detailed, including storage instructions at controlled room temperature. Each container contains 647 mg of iohexol, 600 mg of glycine-bound iodine, 1 mg of edetate calcium disodium, and 121 mg of sodium in 1 mL. This product is labeled as Omnipaque™.*
Principal Display Panel (350 mg Iodine/mL Bottle Box Label)
This is a description of a pharmaceutical product from GE Healthcare labeled as v-5481, containing 10 bottles of 500mL each. The product is identified by the NDC code 0407-16126-72, representing OMNIPAQUE™ (iohexol) Injection for intravenous use. It is specified as a pharmacy bulk package and not for direct infusion or intrathecal use. The product is intended for use in arteries, veins, and orally. For more information, contact GE Healthcare in Marlborough, MA, USA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
